Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

August 2028 63

  1. Primary completion A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07839936

  2. Study completion Bachmann's Bundle Versus Right Atrial Appendage Pacing Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07874763

  3. Study completion Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07279259

  4. Study completion A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07351058

  5. Primary completion A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07351058

  6. Study completion A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07784270

  7. Primary completion A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07784270

  8. Study completion PVI Alone Versus PVI Plus PWI and SVCI With PFA Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07405359

  9. Primary completion PVI Alone Versus PVI Plus PWI and SVCI With PFA Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07405359

  10. Primary completion Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05556460

  11. Study completion THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06559891

  12. Primary completion A Study of Cardiovascular Events iN Diabetes Plus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05441267

  13. Primary completion A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07915609

  14. Study completion Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06586203

  15. Primary completion Digoxin and Senolysis in Heart Failure and Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06240403

  16. Study completion A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07931495

  17. Study completion Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07290699

  18. Study completion Efficacy and Safety of Intra-Arterial Albumin as Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07365475

  19. Study completion A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07584967

  20. Study completion A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07691307

  21. Primary completion A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07691307

  22. Study completion Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05331144

  23. Study completion tACS to Enhance Language Abilities Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06092814

  24. Primary completion tACS to Enhance Language Abilities Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06092814

  25. Primary completion Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07001800

  26. Primary completion Smart Technologies in Early Post-Stroke Rehabilitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07171073

  27. Primary completion Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07273838

  28. Study completion Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07278531

  29. Primary completion Adaptive Dietary Intervention (ADI) for Asian Americans With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07278531

  30. Study completion Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07519044

  31. Study completion HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07721584

  32. Primary completion Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07746882

  33. Study completion Vortosiran in Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07870889

  34. Primary completion Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07920055

September 2028 58

  1. Primary completion Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03264352

  2. Study completion Pulmonary Artery Catheter in Cardiogenic Shock Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05485376

  3. Study completion LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06865885

  4. Study completion Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07018297

  5. Primary completion Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07018297

  6. Primary completion Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07092709

  7. Primary completion Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07276282

  8. Primary completion Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07736313

  9. Primary completion Ablation With Transcatheter Edge-to-edge Repair for Atrial Functional Mitral Regurgitation and Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07744035

  10. Primary completion Prevention of Ischemic Stroke Recurrence Using Digital Technology Application Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07825311

  11. Study completion The OXY-VENT Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07870551

  12. Study completion The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02973529

  13. Study completion Physician-modified Endovascular Graft for Repair of Complex Thoracoabdominal and Abdominal Aortic Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04526938

  14. Primary completion Physician-modified Endovascular Graft for Repair of Complex Thoracoabdominal and Abdominal Aortic Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04526938

  15. Primary completion MLC1501 Study Assessing Efficacy in STROke Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05046106

  16. Primary completion PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05934487

  17. Study completion NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06511505

  18. Study completion Efficacy of Daily IV Administration of Dornase Alfa up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence at 6 Months Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06723717

  19. Primary completion The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07513883

  20. Study completion Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07585968

  21. Primary completion GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07617155

  22. Primary completion A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07642050

  23. Study completion Comparing Suture vs. Combined Closure Strategies for Large Blood Vessel Access in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07743697

  24. Primary completion Comparing Suture vs. Combined Closure Strategies for Large Blood Vessel Access in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07743697

  25. Study completion A Trial of CRD-4730 in HFrEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07750873

  26. Primary completion A Trial of CRD-4730 in HFrEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07750873

  27. Study completion Effectiveness and Cost-Effectiveness of a Digital Care Pathway and Asynchronous Communication for Patients With Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07812350

  28. Primary completion Pulsed Field Ablation for Paroxysmal Atrial Fibrillation: Clinical Efficacy and Left Atrial Function Protection Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07865221

  29. Study completion Continuous Glucose Monitoring and Dietary Self-Management in Adults in Namwon Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07890740

  30. Primary completion Impact of Atrial Fibrillation Prediction Model on Prescribing Oral Anti-Coagulation in Patients With Cryptogenic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07934511

  31. Primary completion Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07866066

  32. Study completion Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02472028

  33. Primary completion Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02472028

  34. Study completion Evaluation of Safety and Effectiveness of Stryker Surpass Evolve™ Flow Diverter System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04195568

  35. Study completion The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05095857

  36. Primary completion The Anaesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05095857

  37. Study completion Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07604922

  38. Primary completion Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06768138

  39. Primary completion LAAO Versus NOAC in Patients with AF and PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05353140

  40. Study completion The COMPLETE Treatment of Bifurcation With Two-stent Techniques: Randomized Comparison of Crush Versus Culotte Technique Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05488665

  41. Study completion IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07875179

  42. Primary completion IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07875179

  43. Primary completion Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06523959

  44. Primary completion TAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06597188

  45. Study completion TENS for Limb Function in Stroke: Design and Rationale for a Randomized Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06997744

  46. Primary completion STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07007143

  47. Study completion AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07555730

  48. Primary completion AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07555730

  49. Study completion Sublingual Edaravone Dexborneol for Inter-hospital Transfer Acute Ischemic Stroke (SLEDAIS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07682922

  50. Primary completion A Study of BGM0504 in Early T2DM With Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07743983

  51. Primary completion The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07818083

  52. Primary completion Comparison of Fractional FLOW Reserve Outcomes With Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Percutaneous Coronary Intervention Strategies Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07852689

October 2028 50

  1. Study completion Effects of Carnosine In Patients With Peripheral Arterial Disease Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06480760

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke Registry record

    Expected 2024-05-01; that period ended on 2024-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05745311

  2. Study start Effects of Individualized iTBS on Upper Limb Function After Stroke Registry record

    Expected 2024-05-01; that period ended on 2024-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06147167

  3. Study start The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction Registry record

    Expected 2024-05-01; that period ended on 2024-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06350487

  4. Study start Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients Registry record

    Expected 2024-05-01; that period ended on 2024-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06381947

  5. Study completion Screening of OSA in Hospitalized Stroke Patients Using BSP Registry record

    Expected 2024-05-03; that period ended on 2024-05-03.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05466864

  6. Primary completion Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions Registry record

    Expected 2024-05-05; that period ended on 2024-05-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04561739

  7. Primary completion Repository of Phase Signals for Pulmonary Hypertension Algorithm Development Registry record

    Expected 2024-05-15; that period ended on 2024-05-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04031989

  8. Primary completion Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis Registry record

    Expected 2024-05-20; that period ended on 2024-05-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05540587

  9. Primary completion a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency Registry record

    Expected 2024-05-24; that period ended on 2024-05-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05922436

  10. Study completion a Study Evaluating the Safety and Efficacy of Clevidipine for Patients Who With Hypertensive Emergency and Sub-emergency Registry record

    Expected 2024-05-25; that period ended on 2024-05-25.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05922436

  11. Study completion Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis Registry record

    Expected 2024-05-30; that period ended on 2024-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04815785

  12. Study completion The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery Registry record

    Expected 2024-05-30; that period ended on 2024-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05006287

  13. Primary completion The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery Registry record

    Expected 2024-05-30; that period ended on 2024-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05006287

  14. Study completion Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis Registry record

    Expected 2024-05; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02657707

  15. Primary completion Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease Registry record

    Expected 2024-05; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04258397

  16. Primary completion Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting Registry record

    Expected 2024-05-31; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04904250

  17. Study completion The Flow Diverter for Treating Patients With Intracranial Aneurysms Registry record

    Expected 2024-05-31; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05060185

  18. Study completion Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease Registry record

    Expected 2024-05; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05373004

  19. Primary completion A Prospective, Multicenter Study to Evaluate the JensClip Transcatheter Valve Repair System Registry record

    Expected 2024-05; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05417945

  20. Study completion Prophylactic Effects of Agomelatine for Poststroke Depression Registry record

    Expected 2024-05-31; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05426304

  21. Primary completion Prophylactic Effects of Agomelatine for Poststroke Depression Registry record

    Expected 2024-05-31; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05426304

  22. Study completion Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy Registry record

    Expected 2024-05; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05626972

  23. Primary completion Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin. Registry record

    Expected 2024-05-31; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05760456

  24. Study completion The Effects of Allicor on Patients After Revascularization Treatment During a Year Registry record

    Expected 2024-05-31; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05813171

  25. Study completion Evaluation of the Effectiveness and Safety of ABAStroke Registry record

    Expected 2024-05-31; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05979324

  26. Primary completion A Study Evaluating the Safety and Efficacy of Neuroprotective Peptide CN-105 Peptide in Patients With Acute Supratentorial Intracerebral Hemorrhage Registry record

    Expected 2024-05; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06255977

  27. Study start Cardiac Interventional ICE Imaging Trial Registry record

    Expected 2024-05; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06344494

  28. Study start Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels Registry record

    Expected 2024-05; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06345209

  29. Study start Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke Registry record

    Expected 2024-05; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06374823

  30. Study start Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients Registry record

    Expected 2024-05-31; that period ended on 2024-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06417489

  31. Study completion Lovastatin for Treatment of Brain Arteriovenous Malformations Registry record

    Expected 2024-06-01; that period ended on 2024-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04297033

  32. Primary completion Lovastatin for Treatment of Brain Arteriovenous Malformations Registry record

    Expected 2024-06-01; that period ended on 2024-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04297033

  33. Study completion Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery Registry record

    Expected 2024-06-01; that period ended on 2024-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05084118

  34. Primary completion Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Lower Extremity Arteriosclerosis Occlusive Lumen Registry record

    Expected 2024-06-01; that period ended on 2024-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05625711

  35. Study completion Follow up of Clinical Outcome of Deferred vs Immediate Stenting in High Thrombus Stemi Patients Registry record

    Expected 2024-06-01; that period ended on 2024-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05793671

  36. Study start METFORMIN FOR ATRIAL FIBRILLATION Registry record

    Expected 2024-06-01; that period ended on 2024-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05878535

  37. Primary completion Evaluation of a Proactive Clinical Management and Early Diagnosis of Arrhythmias in Patients With Heart Failure and Non Severely Reduced Left Ventricular Function Through a Telemonitoring System Registry record

    Expected 2024-06-01; that period ended on 2024-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05974306

  38. Primary completion Three Dimensional Navigation IntraCardiac Guidance Kit for Atrial Septal Puncture Registry record

    Expected 2024-06-01; that period ended on 2024-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06188351

  39. Study start TEC4Home Blood Pressure Randomized Controlled Trial Registry record

    Expected 2024-06-01; that period ended on 2024-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06303206

  40. Study start Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndrome and Non-Acute Coronary Syndrome Related Cardiogenic Shock Registry record

    Expected 2024-06-01; that period ended on 2024-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06414187

  41. Primary completion Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure Registry record

    Expected 2024-06-07; that period ended on 2024-06-07.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05816733

  42. Primary completion Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial Registry record

    Expected 2024-06-12; that period ended on 2024-06-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03108456

  43. Study completion EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction Registry record

    Expected 2024-06-12; that period ended on 2024-06-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05020704

  44. Primary completion EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction Registry record

    Expected 2024-06-12; that period ended on 2024-06-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05020704

  45. Study start A Comparative Study Evaluating the Vein of MArshall Ethanol Infusion Ablation Using an Over-the-wire (OTW) Balloon Versus a microcatHeter in Patients With Atrial Fibrillation Registry record

    Expected 2024-06-15; that period ended on 2024-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06460831

  46. Study completion Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension Registry record

    Expected 2024-06-24; that period ended on 2024-06-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04474899

  47. Study completion Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS) Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01650792

  48. Primary completion Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS) Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01650792

  49. Study completion Trial for MicroPort's Firesorb BVS: FUTURE-III Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03660202

  50. Study completion PIONEER Trial:Hemodynamic Support With ECMO and IABP in Elective Complex High-risk PCI Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04045873

  51. Primary completion ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction Registry record

    Expected 2024-06-30; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04476173

  52. Study completion Magnesium Treating Subarachnoid Hemorrhage Vasospasm Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04613960

  53. Primary completion Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease. Registry record

    Expected 2024-06-30; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04619927

  54. Study completion Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome Registry record

    Expected 2024-06-30; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04718025

  55. Primary completion Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome Registry record

    Expected 2024-06-30; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04718025

  56. Study completion Investigational Study of Delayed Release Metformin Registry record

    Expected 2024-06-30; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04854512

  57. Primary completion Hemodynamic Optimization of Cerebral Perfusion After Endovascular Therapy in Patients With Acute Ischemic Stroke Registry record

    Expected 2024-06-30; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04892511

  58. Study completion Rotablation vs Intravascular Lithotripsy in Calcified Coronary Lesions Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04960319

  59. Study completion Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction Registry record

    Expected 2024-06-30; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04984954

  60. Primary completion Valveclip® Transcatheter Mitral Valve Repair Study Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05021614

  61. Primary completion Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05041010

  62. Primary completion Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D Registry record

    Expected 2024-06-30; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05140694

  63. Study completion Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05294887

  64. Primary completion Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05294887

  65. Study completion The Multicenter Clinical Trial of a Novel TEER Decive (V-CLASP Trial) Registry record

    Expected 2024-06-30; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05391802

  66. Study completion Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol Registry record

    Expected 2024-06-30; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06248242

  67. Primary completion Treatment of Acute Ischemic Stroke With Rt-PA Combined With Edaravone Dexborneol Registry record

    Expected 2024-06-30; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06248242

  68. Study start Advapro Coronary Stent System in Coronary Artery Diseased Patients. Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06300268

  69. Study completion Oral Enteral Nutrition Tube Feeding on Stroke Survivors Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06301646

  70. Primary completion Oral Enteral Nutrition Tube Feeding on Stroke Survivors Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06301646

  71. Study start SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06442280

  72. Study start Henagliflozin's Impact on Prediabetes Remission Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06448130

  73. Study start Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD Registry record

    Expected 2024-06; that period ended on 2024-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06449833

  74. Study start Quelling of Excitotoxicity in Acute Stroke With Ketamine Registry record

    Expected 2024-07-01; that period ended on 2024-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03223220

  75. Primary completion Diabetes Discharge Transitional CGM Study (DDT-CGM) Registry record

    Expected 2024-07-01; that period ended on 2024-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04729985

  76. Study completion Effects of Individualized Accurate Positioning TMS Based on Task fMRI Activation on Upper Extremity Function After Stroke Registry record

    Expected 2024-07-01; that period ended on 2024-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05440292

  77. Primary completion Effects of Individualized Accurate Positioning TMS Based on Task fMRI Activation on Upper Extremity Function After Stroke Registry record

    Expected 2024-07-01; that period ended on 2024-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05440292

  78. Study completion The Safety and Efficacy of Embotrap in Treating Acute Ischemic Stroke Patients Registry record

    Expected 2024-07-01; that period ended on 2024-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05667103

  79. Primary completion The Safety and Efficacy of Embotrap in Treating Acute Ischemic Stroke Patients Registry record

    Expected 2024-07-01; that period ended on 2024-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05667103

  80. Study completion Medical Monitoring of Older Adults Patients After Discharged From Heart Failure Hospitalization Registry record

    Expected 2024-07-01; that period ended on 2024-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06018532

  81. Study start Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis Registry record

    Expected 2024-07-01; that period ended on 2024-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06243133

  82. Study start REstoration of VItamin D in Pulmonary Arterial Hypertension Registry record

    Expected 2024-07-01; that period ended on 2024-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06258850

  83. Study start Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions Registry record

    Expected 2024-07-01; that period ended on 2024-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06441539

  84. Study start Reducing Salt and Sugar in Campus Foods: A Malaysian Study Registry record

    Expected 2024-07-01; that period ended on 2024-07-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06473038

  85. Study completion A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2024-07-20; that period ended on 2024-07-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06256549

  86. Primary completion A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2024-07-20; that period ended on 2024-07-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06256549

  87. Study completion Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation Registry record

    Expected 2024-07-30; that period ended on 2024-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05081310

  88. Primary completion Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation Registry record

    Expected 2024-07-30; that period ended on 2024-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05081310

  89. Study completion Effect of Multielectrode Versus Point-by-Point Mapping on Recurrence of Ventricular Tachycardia in Ischemic Heart Disease Registry record

    Expected 2024-07-30; that period ended on 2024-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05203484

  90. Study completion Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke Registry record

    Expected 2024-07-30; that period ended on 2024-07-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05745311

  91. Study completion COAPT trial

    Expected 2024-07; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS

  92. Study completion Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis Registry record

    Expected 2024-07; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04982367

  93. Primary completion Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis Registry record

    Expected 2024-07; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04982367

  94. Study completion ThrombX Retriever for Acute Ischemic Stroke Trial Registry record

    Expected 2024-07; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05270122

  95. Study completion Evaluation of a Digital Care System in the Follow-Up Care of Atrial Fibrillation Patients Registry record

    Expected 2024-07-31; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05375877

  96. Study completion Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization Registry record

    Expected 2024-07; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05624190

  97. Primary completion Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy Recanalization Registry record

    Expected 2024-07; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05624190

  98. Primary completion Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion Registry record

    Expected 2024-07; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05836766

  99. Primary completion Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR) Registry record

    Expected 2024-07-31; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06101888

  100. Primary completion Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia Registry record

    Expected 2024-07; that period ended on 2024-07-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06153433